Cost effectiveness of cord blood versus bone marrow and peripheral blood stem cells

ClinicoEconomics and Outcomes Research

Volumn 2, Issue 1, 2010, Pages 141-147

  Bart, Thomas ^a  

^a Foundation Swiss Blood Stem Cells   (Switzerland)

Author keywords

Cord blood; Health economy; Hematopoietic stem cell transplantation

Indexed keywords

ARTICLE; BLOOD BANK; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; PERIPHERAL BLOOD STEM CELL; PUBLIC HEALTH; UMBILICAL CORD BLOOD;

EID: 78650698712     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/CEOR.S11210     Document Type: Article

References (11)

1. World Marrow Donor Association. Stem Cell Donor Registries Annual Report 2009. 13th ed. Leiden, Netherlands: WMDA; 2010.
2. Gragert L, Maiers M, Williams E, Confer D, Klitz W. Populationbased models because of depletion of high nucleated cell count (TNC) units with common HLA. Abstract # 114, presented at the 8th Annual International Cord Blood Transplantation Symposium; 2010 Jun 3-5; San Francisco, California.
3. GovTrack.US: a civic project to track Congress. Dec 19, 2005. Text of H.R. 2520 [109th]: Stem Cell Therapeutic and Research Act of 2005. Available from: http://www.govtrack.us/congress/billtext.xpd?bill=h109-2520. Accessed Sept 13, 2010.
4. Swiss Foundation Blood stem cells. The role of SBSC in the context of cord blood donations [updated Sep 2008]. Available from: http://www.bloodstemcells.ch/blood-stem-cells/cord-blood/the-role-of-sbsc/the-role-of-sbsc?set_language=en. Accessed Jun 13, 2010.
5. Bone Marrow Donors Worldwide. Number of donors/CBU's per registry in BMDW. Available from: http://www.bmdw.org/index.php?id=statistics. Accessed May 16, 2010.
6. US Census Bureau. International Data Base. Available from: http://www.census.gov/ipc/www/idb/informationGateway.php. Accessed May 16, 2010.
7. Sirchia G, Rebulla P, Tibaldi S, Lecchi L. Cost of umbilical cord blood units released for transplantation. Transfusion. 1999;39(6):645-650.
8. Howard DH, Maiers M, Kollman C, Logan B, Gragert L, Setterholm M. A cost-benefit analysis of increasing cord blood inventory levels. In: Meyer EA, Hanna K, Gebbie K, editors. Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program. Washington DC: National Academy of Sciences, National Academies Press. 2005; 221-241.
9. Kollman C, Abella E, Baitty RL, et al. Assessment of optimal size and composition of the US national registry of hematopoietic stem cell donors. Transplantation. 2004;78(1):89-95.
10. Welch HG, Larson EB. Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia. N Engl J Med. 1989;321(12): 807-812.
11. Smith TJ, Hillner BE, Schmitz N, et al. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma. J Clin Oncol. 1997;15(1):5-10.